Ming, Simon Wan YauHaughney, JohnRyan, DermotPatel, ShishirOchel, Matthiasd’Alcontres, Martina StagnoThornhill, SusannahKocks, Janwillem W.H.Price, David2019-02-182019-02-182019-02-08Ming, S W Y, Haughney, J, Ryan, D, Patel, S, Ochel, M, d’Alcontres, M S, Thornhill, S, Kocks, J W H & Price, D 2019, 'Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma', npj Primary Care Respiratory Medicine, vol. 29, 3. https://doi.org/10.1038/s41533-019-0115-02055-1010Mendeley: 31a32c95-564a-3d4d-8711-5aa28605f56chttp://hdl.handle.net/2164/11929The authors would like to extend their acknowledgement to Dr. Antony Hardjojo for proof-reading this manuscript. This study is funded by Chiesi Limited. All relevant data are within the paper and the supporting information files. The dataset supporting the conclusions of this article was derived from the UK Optimum Patient Care Research Database (www.opcrd.co.uk). We do not have permission to give public access to these databases; however, researchers may request access for their own purposes. Request for access to OCPRD can be made via the OCPRD website (https://opcrd.co.uk/our-database/data-requests/) or via the enquiries email info@opcrd.co.uk.81737743engSDG 3 - Good Health and Well-beingMETERED-DOSE INHALERCORTICOSTEROID TREATMENTFLUTICASONE PROPIONATECOST-EFFECTIVENESSORAL CANDIDIASISREAL-LIFEBECLOMETHASONEEFFICACYSAFETYPRESCRIPTIONR MedicinePublic Health, Environmental and Occupational HealthPulmonary and Respiratory MedicineRComparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthmaJournal article10.1038/s41533-019-0115-0http://www.scopus.com/inward/record.url?scp=85061264881&partnerID=8YFLogxKhttp://www.mendeley.com/research/comparison-adverse-events-associated-different-spacers-used-nonextrafine-beclometasone-dipropionate29